145 related articles for article (PubMed ID: 11489357)
1. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR.
Zhong CX; Mass MJ
Toxicol Lett; 2001 Jul; 122(3):223-34. PubMed ID: 11489357
[TBL] [Abstract][Full Text] [Related]
2. Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion.
Kuzmin I; Geil L; Ge H; Bengtsson U; Duh FM; Stanbridge EJ; Lerman MI
Oncogene; 1999 Oct; 18(41):5672-9. PubMed ID: 10523847
[TBL] [Abstract][Full Text] [Related]
3. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
4. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman JG; Graff JR; Myöhänen S; Nelkin BD; Baylin SB
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9821-6. PubMed ID: 8790415
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
6. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
7. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
Schroeder M; Mass MJ
Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
9. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
10. Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method.
Kohno T; Kawanishi M; Inazawa J; Yokota J
Hum Genet; 1998 Mar; 102(3):258-64. PubMed ID: 9544836
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
12. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.
Zatyka M; Morrissey C; Kuzmin I; Lerman MI; Latif F; Richards FM; Maher ER
J Med Genet; 2002 Jul; 39(7):463-72. PubMed ID: 12114475
[TBL] [Abstract][Full Text] [Related]
13. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
Walker C; Ahn YT; Everitt J; Yuan X
Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
[TBL] [Abstract][Full Text] [Related]
15. The von Hippel-Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in Caco-2 cells and rat colon mucosa.
Uthus E; Begaye A; Ross S; Zeng H
Biol Trace Elem Res; 2011 Aug; 142(2):223-31. PubMed ID: 20632125
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.
Alleman WG; Tabios RL; Chandramouli GV; Aprelikova ON; Torres-Cabala C; Mendoza A; Rogers C; Sopko NA; Linehan WM; Vasselli JR
Clin Cancer Res; 2004 Oct; 10(20):7011-21. PubMed ID: 15501981
[TBL] [Abstract][Full Text] [Related]
17. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
18. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
[TBL] [Abstract][Full Text] [Related]
20. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
